Atomic AI is a biotechnology company that combines machine learning and structural biology to advance RNA-centric drug discovery. Its foundation model, ATOM-1, enables precise predictions of three-dimensional RNA structures, opening up previously inaccessible targets. The company's proprietary R&D platform integrates deep learning models with in-house wet-lab assays in a virtuous cycle to develop RNA-targeted small molecules and RNA-based therapeutics.
Key Benefits
- World’s most precise predictions of RNA three-dimensional structure via ATOM-1
- Access to previously inaccessible RNA targets
- Integration of machine learning with in-house wet-lab assays
- Focus on both RNA-targeted small molecules and RNA-based therapeutics